AF
LYEL icon

Amalgamated Financial’s Lyell Immunopharma LYEL Stock Holding History

Amalgamated Financial’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$111K Buy
+1,098
New +$133K ﹤0.01% 2109

Other funds holding LYEL

MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
A
Apoletto Road Town, Tortola, British Virgin Islands $260M AUM 31.4% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Amalgamated Financial's LYEL Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Lyell Immunopharma (LYEL) in Q1 2022: 1,098 shares worth $111K. The stake represents ﹤0.01% of the portfolio and ranks #2109 among its holdings.

79 funds tracked by Wall St. Rank hold LYEL as of Q1 2022.

  • Amalgamated Financial held 1,098 shares of Lyell Immunopharma worth $111K as of Q1 2022.
  • Lyell Immunopharma was a new Amalgamated Financial position in Q1 2022.
  • Lyell Immunopharma made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2109 holding.
  • 79 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.